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ABSTRACT 
AIM 
To explore the prescriptions issued to patients with diabetes by nurse independent and 
nurse supplementary prescribers working in general practice.  
 
METHODS 
19 prescriptions were collected and assessed from 4 case-study sites based in general 
practice between October 2007 and September 2008. Prescriptions were collected from 
patients with diabetes whose consultations were videoed for the purposes of research.  
 
RESULTS  
Prescriptions were consistently issued on an appropriate computer generated prescription 
form, written legibly in ink, used the correct terminology, generic prescribing and 
contained an accurate/appropriate product dose and preparation. They were less 
consistent in stating the number of days, quantity of medicine to be supplied, and 
providing clear and accurate instructions on frequency and timing of treatment.  
 
CONLCUSION 
Nurses in general practice are using computer based repeat prescribing systems to issue 
prescriptions to patients for the management of diabetes and its common complications, 
such as hypertension, hyperlipidaemia and cardiovascular disease. Whilst nurse 
prescribers were generally compliant with good practice in prescription writing, they 
need to ensure that they include ongoing information with respect to the number of days 
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of treatment, quantity of medicine to be supplied, and clear and accurate instructions 
regarding the frequency and timing of medicines. 
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INTRODUCTION 
 
Diabetes Mellitus, a progressive disease known to affect at least 3% of the population,  is 
often accompanied by long-term complicated co-morbidities, particularly cardiovascular 
disease, hypertension and hyperlipidaemia (Audit Commission 2000, Healthcare 
Commission (HCC) 2007). In order to manage this disease combination, long-term 
multiple medicines are commonly  prescribed using repeat prescriptions (Stack et al. 
2008).  
 
Repeat prescriptions represent about 80% of the cost and two-thirds of all items 
prescribed in general practice (Haynes et al. 2002, Richard & Lussier 2006, NPSA 2007). 
However, the effectiveness of medicines prescribed in this way largely depends on 
individuals’ adherence to the treatment regimen. Evidence suggests that 10-20% of repeat 
prescriptions never reach a pharmacy (Anderson et al. 2005), and  less than 50% of 
patients are adherent to their medication regimen, which decreases further with multiple 
chronic conditions (Anderson et al. 2005, Hugtenburg et al. 2005, Williams et al. 2009). 
Reasons most frequently reported  for lack of medication adherence include disagreement 
about the need for treatment, difficulty managing the schedule  of medicines,  and not 
wanting to take all medications (Stack et al. 2008, Williams et al. 2009),  perceived 
effectiveness, side-effects, concern about possible side-effects and inadequate 
information (Hugtenburg et al. 2005).  
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The likelihood of medication adherence is increased  however, when patients receive 
accurate, clearly written prescriptions, which include detailed information and 
instructions on how to take the medicine (Winslow et al. 1997, NPSA 2007). Every 
attempt should therefore be made to ensure that prescriptions include this information. 
Although the prescription format may vary slightly between primary and secondary care, 
a number of agreed core elements should be present (World Health Organization 1994, 
BMA 2008). This includes the prescribers details (i.e. name, address, telephone number 
and signature), date, age and date of birth (if <12 years of age), full drug name 
(preferably generic), dose and frequency, number of days of treatment, and the quantity 
of medicine to be supplied.  
 
Recent legislative changes (DoH 2002,  2003,  2005,  2006) to the policy surrounding the 
prescription of medicines have enabled a number of healthcare professionals, including 
nurses, pharmacists, optometrists, podiatrists and physiotherapists, prescribing rights in 
the UK; this has effectively provided around 14,000 nurses virtually the same prescribing 
rights as doctors (NMC 2007). Evidence from a national survey in 2006 suggests that 
nearly a third of these nurses prescribe for patients with diabetes (Courtenay & Carey 
2008b), and that they are predominantly based in  general practice (Carey & Courtenay 
2007). Examination of the prescribing patterns of these nurses also indicates that the 
majority frequently prescribe oral hypoglycaemic medication, insulin, antihypertensive 
and lipid regulating drugs (Carey & Courtenay 2008, Courtenay & Carey 2008c). 
However, there is no evidence exploring the extent to which nurse prescribers in general 
practice comply with good practice in prescription writing for patients with diabetes.  
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THE STUDY 
 
AIM 
To explore the prescriptions issued to patients with diabetes by Nurse Independent 
Prescribers and Nurse Supplementary Prescribers (NISPs) working in general practice. 
 
METHODS 
Prescriptions were collected from 4 case study sites based in general practice between 
October 2007 and September 2008. The full case study involved 9 sites, additional 
findings of which are reported elsewhere (Carey & Courtenay 2008, Courtenay & Carey 
2008b,  2008c, Courtenay et al. 2008). Each nurse was asked to collect prescription data, 
where issued, from 5 consultations that they video recorded for research purposes. 
Prescriptions were made anonymous, photocopied, collected and independently assessed, 
by a community consultant diabetologist and nurse consultant, using a prescription 
assessment form. Each assessor rated the various aspects of the prescriptions using 
‘1’=safe practice/accurate, ‘0’=unsafe practice/omitted. Inter-rater reliability was 
supported by pilot work and discussion between the researchers and two assessors about 
how to use assessment form.   
 
PARTICIPANTS 
Nurse prescribers at each case study site included nurse practitioners (n=3) (two nurses 
worked in one site) and practice nurses (n=2). Two nurses had between 1 and 2 years 
prescribing experience whilst 3 nurses had more than 4 years experience.  
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RELIABILITY AND VALDITIY 
The prescription assessment form was developed from previous research (Britten et al. 
2003, Courtenay & Carey 2008a) and the guidelines for prescription writing described in 
the BNF (BMA 2008). The form assessed the following areas: accuracy, legibility, the 
use of correct terminology, generic prescribing, preparation details (i.e. strength), dose, 
dose frequency, length of treatment and instructions regarding the frequency and timing 
of medicines.  
 
ETHICAL APPROVAL 
Study approval was granted by NHS and University of Reading research ethics 
committees and local Research and Development committees.  
 
DATA ANALYSIS 
Microsoft Excel and SPSS version 16 were used for data entry and analysis. Descriptive 
statistics were used to describe the various aspects of the prescription. 
 
RESULTS 
Prescriptions 
Prescriptions issued for 19 patients with diabetes across 4 case study sites were collected 
and assessed. Forty seven medicines, i.e. an average of 2.5 items per prescription, were 
prescribed. All prescriptions were computer generated. The majority were repeat 
prescriptions issued for the ongoing treatment of diabetes and its common co-morbidities.  
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Conditions/Products prescribed  
Table 1 describes the conditions/products that were prescribed. Nearly 25% (n=11) of 
prescribed items were for oral anti-diabetic drugs, while 14.9% (n=7) were for 
hypertension and 12.8% (n=6) lipid regulating drugs. Insulin, monitoring products (for 
blood/urine glucose, ketones and protein), and a number of other therapeutic areas (i.e. 
thyroid, depression, and oral contraception) each accounted for nearly 11% of items that 
were prescribed.  
 
Prescribing documentation 
All prescriptions were written on the appropriate documentation, computer generated, 
and written generically (see Table 2).  
 
Drug Dosage and duration information 
Accurate product information (i.e. strength and preparation) was included on all 
prescriptions (see Table 2). Ninety five percent (n=18) provided information on dose 
frequency and dosage number. Only 58% (n=11) provided information on the quantity of 
medicine to be supplied. Just over 10% (n=2) included information on the number of 
days that treatment was required. 
 
Instructions for patients 
Only 36.8% (n=7) provided clear and accurate instructions regarding the timing and 
frequency of medicines (see Table 2).  
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DISCUSSION 
 
This study is the first to report on the extent to which nurse prescribers in general practice 
comply with good practice in prescription writing for patients with diabetes. This is a 
small study that examined only 19 prescriptions issued by 5 nurses working in general 
practice to patients with diabetes. Prescriptions were not issued on each consultation, 
with the result that 9 (rather than 15) prescriptions were issued for three nurses. 
Additionally, all of the nurses were aware that their prescriptions would be assessed, and 
this may have altered their behaviour. The results lack generalizability to other settings, 
such as secondary care, where nurses also prescribe for patients with diabetes.  Further 
research examining the prescriptions issued by nurses working in other settings and a 
variety of roles, (including diabetes specialist nurses), is therefore required.  
 
In addition to prescribing drugs for diabetes, our findings show nearly 40% of items 
prescribed were for common complications of diabetes including hypertension, 
hyperlipidaemia and cardiovascular disease. These findings are in-line with those 
reported by Courtenay & Carey (2008c) and Carey & Courtenay (2008). Hypertension, 
hyperlipidaemia and cardiovascular disease were also areas in which nurses in this 2006 
national survey reported that they prescribed medicines.  
 
 
Our findings indicate that the prescriptions written by nurses for patients with diabetes 
were consistently issued on an appropriate computer generated prescription form, written 
legibly in ink,  used the correct terminology, generic prescribing, and contained an 
accurate/appropriate product, dose and preparation. There was less evidence of good 
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practice with regards to stating the number of days and quantity of medicine to be 
supplied, and providing clear and accurate instructions with respect to the frequency and 
timing of treatment. Only 2 prescriptions included the number of days treatment, and 
only 7 prescriptions provided instructions on the timing of the medication, a common 
omission being the instruction to take Metformin with food.  
 
Guidance on good prescription writing practice (BMA 2008) states that the total duration 
of treatment or the total number of tablets issued should be written on the prescription. 
These factors were omitted on the majority of prescriptions. Given that the estimated cost 
of unwanted and unused medicines is £100 million a year  (National Collaborating Centre 
for Chronic Conditions (NCCCC) 2009), and a lack of information known to affect 
medication adherence (Hugtenburg et al. 2005, NCCCC 2009), this is an important 
finding. A possible explanation for these omissions is that the majority of prescriptions 
were for ongoing medications. It could be reasonably expected that detailed instructions 
on how to take the medicines had been given on previous prescriptions. Another 
reasonable explanation is that computer based prescribing, as used by nurses in our study 
to issue their prescriptions, has evolved rather than been designed and is therefore, 
subject to local variation. In general repeat prescriptions should be for a maximum of 28 
days or single original pack supply. However, in practice there is a need to provide the 
best balance between patient and practice convenience and the risks of diversion and 
wastage. Use of computer generated prescriptions allow the prescriber to print and sign 
prescriptions for the required repeat medication to be dispensed at set instalments, 28 or 
56 days, for up to a six month period. Whilst computer generated prescriptions prompt 
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the prescriber to select the drug, dose, quantity, and provide instructions for use, this can 
be overridden. It may well be that nurses are prescribing according to local custom or 
practice and repeat prescribing guidance which indicates that the use of "as directed" or 
"no directions" may be appropriate for variable dosage regimes such as insulin (World 
Health Organization 1994).   
 
The assessors commented that patients were verbally informed how to take their 
medicine, and or were provided with written instructions in their diabetes monitoring 
diary (Courtenay et al. 2008). However, it is known that patients often forget a large 
proportion of what has been discussed during the consultation, and frequently rely on 
instructions given on the label (Beckman et al. 2005). Omitting such details could also 
make it difficult for pharmacists to understand exactly what is to be dispensed, and for 
patients to understand when to take their medicine, and adhere to their medication 
regimen. Recent guidance recommends that this information should be provided on an 
ongoing basis, particularly when patients have long-term conditions with multiple 
medications (NCCCC 2009). It is therefore seems important, that nurse prescribers do not 
make assumptions about patient’s ability to understand and remember information they 
have been given concerning treatment duration and timing of medication. Furthermore, in 
order to maximise the likelihood that patients will adhere to their medication regimen, it 
is also important that they ensure each prescription contains adequate information on 
treatment duration, and clear and accurate instructions about, how and when to use the 
medicine.   
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CONCLUSION 
 
Nurses in general practice are using computer based repeat prescribing systems to issue 
prescriptions to patients for the management of diabetes and its common complications, 
such as hypertension, hyperlipidaemia and cardiovascular disease. Whilst nurse 
prescribers were generally compliant with good practice in prescription writing, they 
frequently did not provide information on the number of days, quantity of medicine to be 
supplied, or clear and accurate instructions regarding the frequency and timing of 
medicines. Given that such omissions may contribute to non-adherence of medication 
regimens, resulting in a lack of improvement or deterioration of health, it is important 
every effort is made to ensure that all prescriptions include this information.  
 
 
Key Points 
 Repeat prescriptions represent 80% of the cost and two thirds of all items 
prescribed in general practice 
 Good practice in prescription writing increases the likelihood of medication 
adherence 
 Nurses prescribing for patients with diabetes use the correct documentation, write 
legibly in ink, the correct terminology, generic prescribing and prescribe 
accurate/appropriate products dose and preparation 
 It is important that nurse prescribers make every effort to ensure  all prescriptions 
include information of the  number of days, quantity of medicine to be supplied, 
and clear and accurate instructions about the frequency and timing of medicines 
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 Table 1: Conditions/products prescribed for patients with diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Assessment of Prescriptions 
 
 
 
Conditions/Products 
Total items=47 
 Frequency Percent 
Oral anti-diabetic drugs 11 23.4 
Hypertension 7 14.9 
Lipid regulating drugs 6 12.8 
Insulin 5 10.6 
Monitoring (glucose, etc.) 5 10.6 
Insulin pens, syringes and needles 3 6.4 
Cardiovascular disease 2 4.3 
Management of micro-albuminuria 1 2.1 
Diabetic neuropathy (including erectile 
dysfunction) 1 2.1 
Fungal skin infection 1 2.1 
Other therapeutic areas (including thyroid, 
depression, oral contraception) 5 10.6 
 YES NO 
 % n % n 
Number of days stated 10.5 2 89.5 17 
Clear & accurate instructions re (frequency, 
and timing of  treatment) 
36.8 7 63.2 12 
Quantity in brackets 57.9 11 42.1 8 
Dosage number 94.7 18 5.3 1 
Dose frequency in words 94.7 18 5.3 1 
appropriate generic prescribing 100 19 0 0 
Accurate /appropriate product, dose & 
preparation 
100 19 0 0 
correct terminology 100 19 0 0 
written legibly in ink  100 19 0 0 
uses appropriate prescription / form 100 19 0 0 
